Evidence map›Paper›PMID 40371966›Full record

ReviewClinical and experimental immunology2025

Chronic granulomatous disease: lessons in cell biology from monogenic immunodeficiency.

Paige M Mortimer, Shuli Svetitsky, David C Thomas

Abstract readReview
In one paragraph

Review in Clinical and experimental immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Paige M MortimerCentre for Inflammatory Disease, Department of Immunology & Inflammation, Imperial College, London, UK.
Shuli SvetitskyThe Francis Crick Institute, London, UK.
David C ThomasCambridge Institute for Therapeutic Immunology and Infectious Disease University of Cambridge, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reactive oxygen species (ROS) are produced in immune cells by the phagocyte NADPH oxidase (NOX2) system that carries out coordinated transfer of electrons to molecular oxygen. The importance of the system in host defence and immunoregulation is underlined by chronic granulomatous disease (CGD), a severe monogenic immunodeficiency caused by mutations in genes encoding individual components of NOX2. CGD also leads to inflammatory manifestations due to the regulatory role of ROS in multiple signalling processes. We describe the system in detail, from its discovery to our current understanding of the oxidase. We also describe CGD and illustrate how recent insights into this disease shed light on physiology.

Indexed as

Granulomatous Disease, ChronicMembrane GlycoproteinsNADPH OxidasesAnimalsHumansImmunologic Deficiency SyndromesMutationNADPH Oxidase 2Reactive Oxygen SpeciesSignal TransductionCYBB protein, humanMembrane GlycoproteinsNADPH Oxidase 2NADPH OxidasesReactive Oxygen Specieshost-pathogen interactionsimmunodeficiency diseasesmacrophageneutrophilsreactive oxygen species

Identifiers

PMID40371966
PMCPMC12658887

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.